Home / Companies / Ursapharm Arzneimittel
Company family
Ursapharm Arzneimittel: medicine shortages
As of 2 Nov 2026, 10 Ursapharm Arzneimittel products have a reported shortage across 1 countries, covering 6 medicines.
Where
Which therapeutic classes
Why, compared with all companies
Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.
Latest changes
All changesNo changes recorded yet. Changes are tracked from our daily snapshots.
Open shortages over time
Products short per day in the 5 countries tracked since 31 Oct 2026, from our daily snapshots. The history lengthens every day.
When its current shortages began
Against its peers
Breadth vs depth
Further right: more products short. Higher: more different medicines affected.
Medicines short
Download CSV| Medicine | Where this company is short | Products | Earliest start | Main reason | Short anywhere |
|---|---|---|---|---|---|
| Phenylephrine | 3 | 27 Apr 2026 | Manufacturing problem | 2/16 | |
| Kanamycin | 2 | 23 Jun 2026 | Active ingredient shortage | 2/16 | |
| Prednisolone | 2 | 21 Nov 2024 | Manufacturing problem | 3/16 | |
| Dexamethasone and Antiinfectives | 1 | 28 Jul 2026 | Manufacturing problem | 5/16 | |
| Fluorometholone | 1 | 22 Aug 2024 | Manufacturing problem | 2/16 | |
| Gentamicin | 1 | 30 Jun 2026 | Manufacturing problem | 2/16 |
Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.